SOC TELEMED acquired by PATIENT SQUARE CAPITAL
Context
SOC Telemed completed its acquisition by Patient Square Capital. The strategic rationale is rooted in SOC Telemed’s position as the largest national provider of acute‑care telemedicine in the US, with a scalable enterprise platform, Telemed IQ, and a diverse portfolio of specialty telemedicine services. For Patient Square, the acquisition aligns with a broader thesis of backing capital‑efficient, high‑margin, technology‑enabled healthcare solutions that can standardize and scale virtual care delivery across hospital and health‑system clients. The sponsor’s backing provides SOC Telemed with enhanced capital flexibility to invest in clinical capabilities, product innovation, and geographic expansion while maintaining its existing leadership under Chief Executive Officer Dr. Chris Gallagher.
SOC TELEMED, which reported an EBITDA margin of in 2022, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (15.1x).
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
SOC Telemed, Inc. is a leading national provider of acute care telemedicine technology and solutions, headquartered in Herndon, Virginia. Since 2004, the company has delivered virtual care programs across a broad range of clinical specialties for hospitals, health systems, post‑acute providers, physician networks, and value‑based care organizations. Its enterprise platform, Telemed IQ, is designed to rapidly deploy and centrally manage telemedicine services across the continuum of care, enabling clients to scale programs with minimal operational friction. The company’s business model centers on B2B telemedicine infrastructure and program management, combining technology licensing, professional services, and ongoing support. SOC Telemed offers multiple clinical service lines, including teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, and teleMaternal‑Fetal Medicine, making it one of the most comprehensive acute‑telemedicine vendors in the US. The platform’s enterprise‑grade architecture supports standardization, regulatory compliance, and integration with existing hospital workflows.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (USD)
Similar deals in Software
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2022 | CT ENGINEERING | INFODREAM | FRANCE | Supply Chain & Ops |
| 05/2022 | W.A.G PAYMENT SOLUTIONS | WEBEYE TELEMATICS | HUNGARY | Automotive |
| 04/2022 | SOGELINK | LOCATIQS | NETHERLANDS | Engineering & Design Software |
| 04/2022 | MONTEFIORE INVESTMENT / PLÉIADE INVESTISSEMENT | GENERIX GROUP | FRANCE | Supply Chain & Ops |
| 04/2022 | VERVE | AXESINMOTION | SPAIN | Gaming & Consumer Apps |
| 04/2022 | SOGELINK | FOCUS SOFTWARE | NORWAY | Engineering & Design Software |
| 03/2022 | BPIFRANCE / EURAZEO | DOCTOLIB | FRANCE | Healthcare |
| 03/2022 | APAX PARTNERS | ALCUMUS | UNITED KINGDOM | Industry-Specific Software |
| 03/2022 | ALBAREST / BPIFRANCE | MASA GROUP | FRANCE | Defense & Aerospace |
| 02/2022 | CLEARLAKE CAPITAL | QUEST SOFTWARE | UNITED STATES | Data, Analytics & AI |
REFERENCES
Valuation range: EV 300M - 700M USD
Revenue range: 100M - 200M USD
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SOC TELEMED by PATIENT SQUARE CAPITAL are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: patient square capital